Search

everythinglearnresearchcommunity

for

Search:↓

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Dutasteride mesotherapy can cause hair loss in some people.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

AH-001 could be a safer and more effective treatment for hair loss.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

Dihydrotestosterone (DHT) increases oil production in skin cells by activating mTOR, and mTOR inhibitors can reduce this effect.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Low-dose dutasteride effectively and safely promotes hair growth in men with androgenetic alopecia.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Dutasteride reduces prostate cancer risk by 23% in high-risk men.

A new method was developed to make finasteride for treating hair loss.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

Finasteride helps female-pattern hair loss.